Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
10.90
-0.07 (-0.59%)
Oct 6, 2025, 2:22 PM EDT - Market open
Exagen Market Cap
Exagen has a market cap or net worth of $239.73 million as of October 6, 2025. Its market cap has increased by 385.51% in one year.
Market Cap
239.73M
Enterprise Value
236.42M
1-Year Change
385.51%
Ranking
Category
Stock Price
$10.90
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $239.73M, an increase of 279.89%. That is a compound annual growth rate of 24.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 241.16M | 233.50% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |